Eptifibatide non cyclic impurity

Eptifibatide non cyclic impurity Suppliers list
Company Name: China National Standard Pharmaceutical Corporation Limited
Tel: +8615391658522
Email: overseasales@yongstandards.com
Products Intro: Product Name:Eptifibatide Impurity 5
CAS:135900-78-6
Purity:0.95 Package:Vials
Company Name: Hubei Yangxin Medical Technology Co., Ltd.  
Tel: 15374522761
Email: 3003392093@qq.com
Products Intro: Product Name:Eptifibatide Impurity 5
CAS:135900-78-6
Purity:95% HPLC Package:10mg;25mg;50mg;100mg
Company Name: Nanjing Huanuo Biomedical Technology Co., Ltd  
Tel: 18913906212
Email: 2885426135@qq.com
Products Intro: Product Name:Eptifibatide Impurity 11
CAS:135900-78-6
Purity:98% HPLC Package:mg;g
Company Name: Shenzhen Excellent Biomedical Technology Co., Ltd.  
Tel: 18318671572
Email: 2850803126@qq.com
Products Intro: Product Name:Eptifibatide Impurity 11
Purity:95% HPLC Package:10mg;25mg;50mg;100mg
Company Name: Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd  
Tel: 18162595016
Email: 3287908757@qq.com
Products Intro: Product Name:Eptifibatide Impurity 5
CAS:135900-78-6
Purity:95%+ HPLC Package:10mg;25mg;50mg;100mg;200mg
Eptifibatide non cyclic impurity Basic information
Product Name:Eptifibatide non cyclic impurity
Synonyms:Eptifibatide non cyclic impurity;L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-;Eptifibatide Impurity 10
CAS:135900-78-6
MF:C35H51N11O9S2
MW:833.98
EINECS:
Product Categories:
Mol File:135900-78-6.mol
Eptifibatide non cyclic impurity Structure
Eptifibatide non cyclic impurity Chemical Properties
density 1.55±0.1 g/cm3(Predicted)
pka4.20±0.10(Predicted)
Safety Information
MSDS Information
Eptifibatide non cyclic impurity Usage And Synthesis
Eptifibatide non cyclic impurity Preparation Products And Raw materials
Tag:Eptifibatide non cyclic impurity(135900-78-6) Related Product Information
L-Aspartic acid, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-, (1→3')-disulfide with L-tryptophyl-L-prolyl-L-cysteinamide (9CI) Eptifibatide impurity 3/Deamidated Eptifibatide Impurity/(3R,11S,17S,20S,25aS)-20-((1H-indol-3-yl)Methyl)-17-(carboxymethyl)-11-(4-guanidinobutyl)-1,9,12,15,18,21-hexaoxodocosahydro-1H-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosine-3-carbo Cyclo(L-Pro-L-Trp-) L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, bimol. cyclic (1→1'),(6→6')-bis(disulfide) N-[2-(Phenylmethyl)phenyl]-2-chloroacetamide Acetamide, 2-methoxy-N-[2-(phenylmethyl)phenyl]- Methanone, (2-aminophenyl)phenyl-, hydrazone, (Z)- L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1→7)-disulfide (9CI) Benzamide, N-[(6,11-dihydro-5H-dibenz[b,e]azepin-6-yl)methyl]-2-(hydroxymethyl)- 7-Bromo Epinastine 3'-Hydroxyacetophenone 6-Chloromethylmorphanthridine Acetamide, 2-(1-methylethoxy)-N-[2-(phenylmethyl)phenyl]-